Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in via BCS
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Browse by collection
Authors
About
Podcasts
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Browse by collection
Authors
About
Podcasts
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in via BCS
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Doxorubicin cardiotoxicity
Email alerts
Doxorubicin cardiotoxicity
165 Label-free autofluorescence lifetime to assess changes in myocardial fibrosis and metabolism
in vivo
in a doxorubicin cardiomyopathy heart failure model
BT
Dyer
,
JM
Elder
,
J
Lagarto
,
SE
Harding
,
PMW
French
,
NS
Peters
,
C
Dunsby
,
AR
Lyon
Heart
Jun 2015,
101
(Suppl 4)
A94;
DOI:
10.1136/heartjnl-2015-308066.165
CLINICAL
Cardiovascular medicine
Arrhythmias
Bradyarrhythmias and heart block
(268)
Tachyarrhythmias
(225)
Cardiomyopathy
Dilated cardiomyopathy
(325)
Hypertrophic cardiomyopathy
(388)
Restrictive cardiomyopathy
(36)
Congenital heart disease
(879)
Drugs: cardiovascular system
(10086)
Echocardiography
(2385)
Heart failure
(620)
Hypertension
(3363)
Interventional cardiology
(3322)
Ischaemic heart disease
Acute coronary syndromes
(3126)
Percutaneous intervention
(1096)
Stable coronary heart disease
(210)
Pacing and electrophysiology
(295)
Valvar diseases
Aortic valve disease
(513)
Mitral valve disease
(275)
Right sided valvular heart disease
(159)
Venous thromboembolism
(572)
Diagnostics
Clinical diagnostic tests
(5281)
Endocrinology
Diabetes
(920)
Metabolic disorders
(1160)
Sport and exercise medicine
(6)
NON-CLINICAL
Communication
Epidemiology
(4620)
Health policy
(275)
Healthcare improvement and patient safety
Hospital ratings
Surgical mortality
Occupational and environmental medicine
Disease and health outcomes
Cardiovascular
Smoking and tobacco
Environmental tobacco smoke
Health effects of tobacco use
(31)
Smoking cessation
(70)
Tobacco use
(719)
Special collections
Cardiology in Focus
(55)
Cochrane Corner
(36)
Guidelines, Recommendations and Consensus Statements
(2)
Image challenges
(245)
Press releases
(114)
Review articles
(494)
Education in Heart
(796)
Education in Heart
Acute cardiovascular care
(14)
Acute coronary syndromes
(79)
Arrhythmias
(26)
Atrial fibrillation and flutter
(7)
Cardiovascular prevention
(17)
Chronic ischaemic heart disease
(11)
Clinical pharmacology
(9)
Congenital heart disease in adult patients
(233)
Diseases of the aorta and trauma to the aorta and heart
(2)
Genetics
(2)
Heart failure
(53)
History taking and clinical examination
(8)
Infective endocarditis
(2)
Invasive imaging: cardiac catheterization and angiography
(12)
Myocardial disease
(25)
Non-invasive imaging
(43)
Oncology and the heart
(1)
Pericardial disease
(3)
Peripheral arterial disease
Physical activity and sport in primary and secondary prevention
Pregnancy & heart disease
(4)
Pulmonary arterial hypertension
(6)
Sudden cardiac death & resuscitation
(4)
Syncope
The cardiac consult
(2)
The electrocardiogram
Thromboembolic venous disease
(2)
Valvular heart disease
(113)
Editor's choice
(315)
Open access
(859)
